Mymetics Corp. MYMXE

• Healthcare • Biotechnology • US • USD

SharesGrow Score

19/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Mymetics Corp. (MYMXE) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 18/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

19/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

→ Health

MOAT

46/100

→ Income

GROWTH

40/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — MYMXE

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-0.01

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2011	$-0.04	$179K	$-10.54M	-5887.7%
2012	$-0.02	$3K	$-6.11M	-203700%
2013	$0.02	$4.38M	$6M	137%
2014	$-0.01	$2.4M	$-3.26M	-135.6%
2015	$-0.01	$3.15M	$-3.01M	-95.3%
2016	$-0.02	$1.25M	$-5.96M	-476%
2017	$-0.01	$1.52M	$-4.11M	-271.4%
2018	$-0.01	$967K	$-4.17M	-431.4%
2019	$-0.01	$653K	$-4.19M	-641.2%